Publications
- Myxovirus Resistance Protein A mRNA Expression Kinetics in Multiple Sclerosis Patients Treated with IFN beta2017 | First Faculty of Medicine, Second Faculty of Medicine
- Anti-NMDAR Antibodies in Demyelinating Diseases2017 | Second Faculty of Medicine, Third Faculty of Medicine
- Clinical experience with alemtuzuma2016 | Second Faculty of Medicine
- Effect of LPG-endermotherapy on skin changes resulting from long-term treatment with glatiramer acetate +12015 | Second Faculty of Medicine
- Alemtuzumab in multiple sclerosis treatment2015 | Second Faculty of Medicine
- Pregnancy and multiple sclerosis -outcomes analysis 2003-20112013 | Second Faculty of Medicine
- Interferon-β biological activity; monitoring of the treatment effect in multiple sclerosis patients in the Czcech republic2013 | Second Faculty of Medicine
- Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study2012 | Second Faculty of Medicine
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis2012 | Second Faculty of Medicine
- Impact of Fingolimod Therapy on Magnetic Resonance Imaging Outcomes in Patients With Multiple Sclerosis2012 | Second Faculty of Medicine
Loading network view...
